Free Trial

Blair William & Co. IL Buys 31,821 Shares of Option Care Health, Inc. $OPCH

Option Care Health logo with Medical background

Key Points

  • Blair William & Co. IL increased its holdings in Option Care Health, Inc. by 67.9%, purchasing an additional 31,821 shares during the second quarter, bringing total holdings to 78,693 shares valued at $2,556,000.
  • Multiple hedge funds have recently modified their stakes in Option Care Health, with institutional investors now owning 98.05% of the company’s stock.
  • Wall Street analysts have mixed ratings for Option Care Health, with an average consensus target price of $35.11 and a majority rating it as a Moderate Buy.
  • Five stocks to consider instead of Option Care Health.

Blair William & Co. IL lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 67.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,693 shares of the company's stock after purchasing an additional 31,821 shares during the quarter. Blair William & Co. IL's holdings in Option Care Health were worth $2,556,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. USA Financial Formulas purchased a new stake in Option Care Health in the second quarter worth about $26,000. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of Option Care Health by 11.8% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 883,404 shares of the company's stock valued at $28,693,000 after purchasing an additional 92,984 shares during the last quarter. TD Private Client Wealth LLC lifted its stake in shares of Option Care Health by 16.5% in the 2nd quarter. TD Private Client Wealth LLC now owns 8,000 shares of the company's stock valued at $260,000 after purchasing an additional 1,133 shares during the last quarter. Sheets Smith Wealth Management lifted its stake in shares of Option Care Health by 1.9% in the 2nd quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company's stock valued at $810,000 after purchasing an additional 457 shares during the last quarter. Finally, Wedge Capital Management L L P NC raised its holdings in shares of Option Care Health by 12.8% in the second quarter. Wedge Capital Management L L P NC now owns 133,389 shares of the company's stock worth $4,332,000 after buying an additional 15,102 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have commented on OPCH. TD Cowen began coverage on Option Care Health in a report on Thursday, October 2nd. They set a "hold" rating and a $30.00 price objective on the stock. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Tuesday, September 23rd. JMP Securities increased their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Option Care Health in a research report on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Option Care Health has an average rating of "Moderate Buy" and a consensus target price of $35.11.

Check Out Our Latest Report on OPCH

Option Care Health Price Performance

Shares of Option Care Health stock opened at $27.10 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The business has a 50-day moving average price of $28.05 and a 200 day moving average price of $30.43. The firm has a market cap of $4.40 billion, a PE ratio of 21.68, a P/E/G ratio of 1.62 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.Option Care Health's quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The shares were purchased at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the acquisition, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the firm's stock in a transaction on Tuesday, September 9th. The shares were purchased at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the purchase, the director directly owned 15,501 shares of the company's stock, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 59,411 shares of company stock worth $1,627,576. Insiders own 0.64% of the company's stock.

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.